DIALYSIS · CCN 552583

USRC Rosemead Dialysis

Rosemead, CA 91770

DialysisProfitUS Renal Care, Inc.
$4.1M
TOTAL REVENUE
-4.0%
OPERATING MARGIN
3 / 5
STAR RATING
14
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.1M
Total costs
$4.2M
Operating income (rev − costs)
−$162K
Operating margin
-4.0%
Total charges
$4.1M
Total treatments
11,062
Dialysis stations
18

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

14 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9873—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0937—
Fistula Rate
DFC_FISTULA_RATE
65.477—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
8——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
135.759—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
176—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.36——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1377—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
32.9272—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
22.353—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
34.834—
Standardized ED Visits Ratio
DFC_SEDR
0.7442—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
4.536—